APOLLO HOSPITALS ENTER. L vs INDRAPRASTHA MEDICAL CORP

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and INDRAPRASTHA MEDICAL CORP (INDRAMEDCO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, INDRAPRASTHA MEDICAL CORP leads APOLLOHOSP vs INDRAMEDCO on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability04
  • Growth20
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

INDRAMEDCO takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

64.33
P/E ratio
17.51
12.55
P/B ratio
4.57
0.23%
Dividend yield
1.08%
₹135.04
EPS
₹20.03

Profitability

INDRAMEDCO takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
24.83%
18.00%
Return on capital
36.00%
15.00%
EBITDA margin
18.00%
7.94%
Net margin
12.39%

Growth

APOLLOHOSP takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
10.49%
33.39%
Profit CAGR (3Y)
28.77%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.25L Cr
Market cap
₹3,226 Cr
₹25,228 Cr
Revenue
₹1,483 Cr
₹2,003 Cr
Net profit
₹184 Cr
0.32
Debt / equity
0.05
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
INDRAPRASTHA MEDICAL CORP
  • + ["Company is almost debt free.", "Company has delivered good profit growth of 132% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 28.8%", "Company has been maintaining a healthy dividend payout of 26.3%"]
APOLLO HOSPITALS ENTER. L full analysis INDRAPRASTHA MEDICAL CORP full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.